Literature DB >> 35693412

Potential of extracellular vesicles and exosomes as diagnostic markers for cholangiocarcinoma.

Linping Cao1, Jiawei Hong2, Jian Wu1.   

Abstract

Entities:  

Year:  2022        PMID： 35693412      PMCID： PMC9186185          DOI： 10.21037/hbsn-2022-02

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   8.265


× No keyword cloud information.
  15 in total

1.  Exosomal piRNA profiling revealed unique circulating piRNA signatures of cholangiocarcinoma and gallbladder carcinoma.

Authors:  Xinjin Gu; Chen Wang; Hui Deng; Chong Qing; Rong Liu; Sanhong Liu; Xinying Xue
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2020-05-26       Impact factor: 3.848

2.  Exosomal miR-200 family as serum biomarkers for early detection and prognostic prediction of cholangiocarcinoma.

Authors:  Ling Shen; Gaoping Chen; Qunfeng Xia; Shijie Shao; Haixing Fang
Journal:  Int J Clin Exp Pathol       Date:  2019-10-01

3.  Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.

Authors:  Ander Arbelaiz; Mikel Azkargorta; Marcin Krawczyk; Alvaro Santos-Laso; Ainhoa Lapitz; Maria J Perugorria; Oihane Erice; Esperanza Gonzalez; Raul Jimenez-Agüero; Adelaida Lacasta; Cesar Ibarra; Alberto Sanchez-Campos; Juan P Jimeno; Frank Lammert; Piotr Milkiewicz; Marco Marzioni; Rocio I R Macias; Jose J G Marin; Tushar Patel; Gregory J Gores; Ibon Martinez; Félix Elortza; Juan M Falcon-Perez; Luis Bujanda; Jesus M Banales
Journal:  Hepatology       Date:  2017-08-26       Impact factor: 17.425

4.  Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma.

Authors:  Emmanouil Sinakos; Amy K Saenger; Jill Keach; W Ray Kim; Keith D Lindor
Journal:  Clin Gastroenterol Hepatol       Date:  2011-02-17       Impact factor: 11.382

Review 5.  Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery.

Authors:  Francesca Raimondo; Lavinia Morosi; Clizia Chinello; Fulvio Magni; Marina Pitto
Journal:  Proteomics       Date:  2011-01-17       Impact factor: 3.984

6.  Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p as potential biomarkers for cholangiocarcinoma.

Authors:  Hye Sook Han; Mi Jin Kim; Joung-Ho Han; Jieun Yun; Hee Kyung Kim; Yaewon Yang; Ki Bae Kim; Seon Mee Park
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2019-11-08

Review 7.  The Tumor Microenvironment in Cholangiocarcinoma Progression.

Authors:  Luca Fabris; Keisaku Sato; Gianfranco Alpini; Mario Strazzabosco
Journal:  Hepatology       Date:  2020-11-06       Impact factor: 17.298

8.  Extracellular vesicle-encapsulated miR-30e suppresses cholangiocarcinoma cell invasion and migration via inhibiting epithelial-mesenchymal transition.

Authors:  Yu Ota; Kenji Takahashi; Shin Otake; Yosui Tamaki; Mitsuyoshi Okada; Kazunobu Aso; Yuichi Makino; Satoshi Fujii; Tsuguhito Ota; Masakazu Haneda
Journal:  Oncotarget       Date:  2018-03-27

9.  Utility of Claudin-3 in extracellular vesicles from human bile as biomarkers of cholangiocarcinoma.

Authors:  Chisaki Ikeda; Hiroaki Haga; Naohiko Makino; Tatsutoshi Inuzuka; Ayako Kurimoto; Toshiki Ueda; Akiko Matsuda; Yasuharu Kakizaki; Tetsuya Ishizawa; Toshikazu Kobayashi; Shinpei Sugahara; Michihiko Tsunoda; Kensei Suda; Yoshiyuki Ueno
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

10.  The diagnostic/prognostic potential and molecular functions of long non-coding RNAs in the exosomes derived from the bile of human cholangiocarcinoma.

Authors:  Xianxiu Ge; Youli Wang; Junjie Nie; Quanpeng Li; Lingyu Tang; Xueting Deng; Fei Wang; Boming Xu; Xiaochao Wu; Xiuhua Zhang; Qiang You; Lin Miao
Journal:  Oncotarget       Date:  2017-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.